Collaborations to Enhance Drug Development and Regulatory Science
HHS-FDA Forecasted FOR-FD-24-014Description
This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Critical Path Initiative and to support regulatory science efforts. FDA and grantees will work together to develop innovative, collaborative projects in research, education, and outreach. These projects can help foster drug product innovation to 1) support efforts to accelerate drug product development; 2) support approaches to advanced manufacturing; 3) facilitate translation of basic science discoveries into therapeutics; and 4) facilitate approaches to enhance the safety, efficacy, quality, and performance of drug products. Projects are identified by FDA. Multiple awards may be funded under this NOFO and are directly dependent on drug development priorities and subject to the availability of funding.
Funding Details
- Award Floor
- $5,000,000.00
- Award Ceiling
- $5,000,000.00
- Total Estimated Funding
- Not specified
- Expected Awards
- 6
Key Dates
- Posted
- November 30, 2023
- Closes
- N/A
- Archive Date
- N/A
Agency Information
- Agency Name
- HHS-FDA
- Agency Code
- HHS-FDA
- Funding Instrument
- Other